John Rende launching Copernicus Capital Management; Bolstering the Bay Area’s roster of Healthcare Hedge Funds

July 15th, 2013
| More
Weintraub Capital Management veteran John Rende has recently founded Copernicus Capital Management with plans to launch the firm’s flagship hedge fund this fall. Rende’s firm is based in San Francisco and will employ a healthcare focused long/short equity strategy.

While the greater New York City area houses the greatest number of healthcare focused hedge funds, the addition of Copernicus Capital Management further solidifies the San Francisco Bay Area's positioning as the second most popular city for healthcare focused hedge funds. According to the most recent Top 50 Healthcare, Pharma & Biotech Hedge Fund List, twenty-eight of the top healthcare funds are headquartered in New York City, while eight are located in San Francisco.

John Rende spent more than 16 years of his career at Jerry Weintraub’s Weintraub Capital Management, which announced that it was being converted into a family office late last year. During his last 13 years at Weintraub Capital, Rende was a senior portfolio manager with responsibility for managing the firm’s healthcare portfolio.

Copernicus Capital Management is aiming to have at least $50 million in assets under management for its expected launch in October.
See Source
For Detailed Investor Profiles on these Investors, click below:
Weintraub Capital Management*
Related People: Jerald Weintraub
Related Entities: Prism Partners I; Prism Partners II Offshore; Prism Partners III Leveraged LP; Prism Partners IV Leveraged Offshore; Weintraub Capital
Related Article Tags: Multi-Strategy, Long Short, Equity, Debt and Global Macro Hedge Fund News; Hedge Fund Jobs, Hirings and Firings; Hedge Fund Launches and Hedge Fund Closings

More Recent Headlines

Bill Ackman Steers Pershing Square Capital towards another Billion Dollar Activist Stake

Richard Perry’s Perry Capital Seeks Injunction against Treasury’s Fannie Mae Profit Grab

Millennium Management LLC Gains Top Trader Nicholas Wells as Nomura Loses Steam

Long/Short Hedge Funds Gain Traction in June Sell-Off; Lansdowne & Horseman Capital Lead the Way

SkyBridge Capital and Woori I&S Announce Strategic Partnership

Top Healthcare and Biotech Focused Hedge Funds Oversee $43 Billion in Equity Assets

Former UBS Hedge Fund Manager Expands MST Capital’s Reach in Asia-Pacific

Dinakar Singh’s TPG-Axon Capital ousts SandRidge Energy’s CEO

Top New York Hedge Funds see assets jump by 21% YTD; Two Sigma & Renaissance Technologies surge

AIFMD – What you should be doing to comply (Part II)